Published in J Neural Transm (Vienna) on August 14, 2013
Catecholaminergic based therapies for functional recovery after TBI. Brain Res (2015) 0.76
Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science (1993) 33.32
Domain interaction between NMDA receptor subunits and the postsynaptic density protein PSD-95. Science (1995) 8.61
A review of central 5-HT receptors and their function. Neuropharmacology (1999) 6.13
The principal features and mechanisms of dopamine modulation in the prefrontal cortex. Prog Neurobiol (2004) 5.66
Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav (2002) 4.54
S100 proteins: structure, functions and pathology. Front Biosci (2002) 3.28
Glutamate as a neurotransmitter in the brain: review of physiology and pathology. J Nutr (2000) 3.19
The role of excitatory amino acids and NMDA receptors in traumatic brain injury. Science (1989) 3.14
A mechanistic account of striatal dopamine function in human cognition: psychopharmacological studies with cabergoline and haloperidol. Behav Neurosci (2006) 2.56
Extent of microstructural white matter injury in postconcussive syndrome correlates with impaired cognitive reaction time: a 3T diffusion tensor imaging study of mild traumatic brain injury. AJNR Am J Neuroradiol (2008) 2.55
beta A4 amyloid protein deposition in brain after head trauma. Lancet (1991) 2.41
Multiple dopamine receptor subtypes in the medial prefrontal cortex of the rat regulate set-shifting. Neuropsychopharmacology (2006) 2.19
Apolipoprotein E alleles as risk factors in Alzheimer's disease. Annu Rev Med (1996) 2.04
Performance deficit of alpha7 nicotinic receptor knockout mice in a delayed matching-to-place task suggests a mild impairment of working/episodic-like memory. Genes Brain Behav (2006) 1.68
Tyrosine hydroxylase and regulation of dopamine synthesis. Arch Biochem Biophys (2010) 1.67
Clinical and pathological correlates of apolipoprotein E epsilon 4 in Alzheimer's disease. Ann Neurol (1996) 1.66
Persistent cognitive dysfunction after traumatic brain injury: A dopamine hypothesis. Neurosci Biobehav Rev (2009) 1.57
A lack of amyloid beta plaques despite persistent accumulation of amyloid beta in axons of long-term survivors of traumatic brain injury. Brain Pathol (2008) 1.46
Neurogenetics and pharmacology of learning, motivation, and cognition. Neuropsychopharmacology (2010) 1.45
Meta-analysis of APOE4 allele and outcome after traumatic brain injury. J Neurotrauma (2008) 1.44
Traumatic brain injury: a risk factor for Alzheimer's disease. Neurosci Biobehav Rev (2012) 1.44
Association of increased cortical soluble abeta42 levels with diffuse plaques after severe brain injury in humans. Arch Neurol (2007) 1.38
Distribution of beta-amyloid protein in the brain following severe head injury. Neuropathol Appl Neurobiol (1995) 1.28
Controlled cortical impact injury affects dopaminergic transmission in the rat striatum. J Neurochem (2005) 1.26
Neurobiological consequences of traumatic brain injury. Dialogues Clin Neurosci (2011) 1.25
Substance P opens cation channels and closes potassium channels in rat locus coeruleus neurons. Neuroscience (1992) 1.19
Monitoring of brain interstitial total tau and beta amyloid proteins by microdialysis in patients with traumatic brain injury. J Neurosurg (2009) 1.17
Pharmacological enhancement of memory and executive functioning in laboratory animals. Neuropsychopharmacology (2010) 1.10
Chronic methylphenidate treatment enhances water maze performance following traumatic brain injury in rats. Neurosci Lett (2000) 1.09
5-HT(7) receptors in the modulation of cognitive processes. Behav Brain Res (2007) 1.06
Recovery of function after brain damage: severe and chronic disruption by diazepam. Brain Res (1986) 1.05
Traumatic brain injury: physiology, mechanisms, and outcome. Curr Opin Neurol (2004) 1.05
Human cognitive flexibility depends on dopamine D2 receptor signaling. Psychopharmacology (Berl) (2011) 1.03
Amantadine enhancement of arousal and cognition after traumatic brain injury. Ann Pharmacother (2008) 1.01
A critical analysis of the role of the neurotrophic protein S100B in acute brain injury. J Neurotrauma (2006) 1.01
Traumatic brain injury-induced cognitive and histological deficits are attenuated by delayed and chronic treatment with the 5-HT1A-receptor agonist buspirone. J Neurotrauma (2012) 1.00
Substance P is associated with the development of brain edema and functional deficits after traumatic brain injury. J Cereb Blood Flow Metab (2009) 1.00
Time dependent alterations in dopamine tissue levels and metabolism after experimental traumatic brain injury in rats. Neurosci Lett (2004) 1.00
Genetic association studies in patients with traumatic brain injury. Neurosurg Focus (2010) 0.99
Allopregnanolone inhibits learning in the Morris water maze. Brain Res (2002) 0.99
Pharmacological management of neurobehavioral disorders following traumatic brain injury--a state-of-the-art review. J Rehabil Res Dev (2009) 0.98
Impairment of GABAA receptor function by N-methyl-D-aspartate-mediated calcium influx in isolated CA1 pyramidal cells. Neuroscience (1994) 0.97
Central acetylcholinesterase inhibitors in the treatment of chronic traumatic brain injury-clinical experience in 111 patients. Prog Neuropsychopharmacol Biol Psychiatry (2004) 0.95
Delayed reduction in hippocampal postsynaptic density protein-95 expression temporally correlates with cognitive dysfunction following controlled cortical impact in mice. J Neurosurg (2010) 0.94
The GABAA receptors. From subunits to diverse functions. Ion Channels (1996) 0.93
Effect of glutamate and blood glutamate scavengers oxaloacetate and pyruvate on neurological outcome and pathohistology of the hippocampus after traumatic brain injury in rats. Anesthesiology (2012) 0.93
Alterations in cerebrospinal fluid apolipoprotein E and amyloid beta-protein after traumatic brain injury. J Neurotrauma (2003) 0.93
Increased anticholinergic sensitivity following closed skull impact and controlled cortical impact traumatic brain injury in the rat. J Neurotrauma (1994) 0.92
Increase of GABAA receptor-mediated tonic inhibition in dentate granule cells after traumatic brain injury. Neurobiol Dis (2010) 0.92
New perspectives on amyloid-beta dynamics after acute brain injury: moving between experimental approaches and studies in the human brain. Arch Neurol (2010) 0.92
Reduced evoked release of acetylcholine in the rodent hippocampus following traumatic brain injury. Pharmacol Biochem Behav (1996) 0.90
Ventral hippocampal alpha7 and alpha4beta2 nicotinic receptor blockade and clozapine effects on memory in female rats. Psychopharmacology (Berl) (2006) 0.88
Glutamate and GABA synthesis, release, transport and metabolism as targets for seizure control. Neurochem Int (2012) 0.88
Reactive astrocytes express substance-P immunoreactivity in the adult forebrain after injury. Neuroreport (1995) 0.86
Traumatic brain injury and the effects of diazepam, diltiazem, and MK-801 on GABA-A receptor subunit expression in rat hippocampus. J Biomed Sci (2010) 0.86
Chicks injected with antisera to either S-100 alpha or S-100 beta protein develop amnesia for a passive avoidance task. Neurobiol Learn Mem (1997) 0.85
The role of glutamate receptors in traumatic brain injury: implications for postsynaptic density in pathophysiology. Brain Res Bull (2011) 0.85
Neuropsychological test performance in healthy volunteers before and after donepezil administration. J Psychopharmacol (2004) 0.85
Rehabilitation pharmacology: bridging laboratory work to clinical application. J Head Trauma Rehabil (2005) 0.85
Role of tachykinin NK receptors on the local and remote injuries following ischaemia and reperfusion of the superior mesenteric artery in the rat. Br J Pharmacol (2002) 0.84
The combined use of amantadine and l-dopa/carbidopa in the treatment of chronic brain injury. Brain Inj (1997) 0.84
Fluid percussion injury causes loss of forebrain choline acetyltransferase and nerve growth factor receptor immunoreactive cells in the rat. J Neurotrauma (1994) 0.84
Controlled cortical impact injury influences methylphenidate-induced changes in striatal dopamine neurotransmission. J Neurochem (2009) 0.84
The role of neuropeptides in learning: focus on the neurokinin substance P. Behav Brain Res (1995) 0.83
Pharmacotherapy of posttraumatic cognitive impairments. Behav Neurol (2006) 0.83
A substance P antagonist reduces axonal injury and improves neurologic outcome when administered up to 12 hours after traumatic brain injury. J Neurotrauma (2011) 0.83
Tolerance development to Morris water maze test impairments induced by acute allopregnanolone. Neuroscience (2006) 0.83
Cerebrospinal fluid apolipoprotein E concentration decreases after traumatic brain injury. J Neurotrauma (2003) 0.83
Protein S-100B as a serum marker of brain damage in severe head injury: preliminary results. Neurosurg Rev (2000) 0.83
Basal and scopolamine-evoked release of hippocampal acetylcholine following traumatic brain injury in rats. Neurosci Lett (1995) 0.83
Traumatic brain injury reduces hippocampal high-affinity [3H]choline uptake but not extracellular choline levels in rats. Neurosci Lett (1994) 0.83
Apolipoprotein E levels in the cerebrospinal fluid of north Indian patients with Alzheimer's disease. Am J Alzheimers Dis Other Demen (2013) 0.81
Substance P increases release of acetylcholine in the dorsal striatum of freely moving rats. Brain Res (1993) 0.81
Gabapentin, A GABA analogue, enhances cognitive performance in mice. Neurosci Lett (2011) 0.81
Marked alterations in the cellular localisation and levels of apolipoprotein E following acute subdural haematoma in rat. Brain Res (1997) 0.81
Measuring serotonin synthesis: from conventional methods to PET tracers and their (pre)clinical implications. Eur J Nucl Med Mol Imaging (2010) 0.80
Serotonergic regulation of associative learning. Behav Brain Res (1996) 0.80
Time course of increased vulnerability of cholinergic neurotransmission following traumatic brain injury in the rat. Behav Brain Res (1995) 0.80
Substance P modulates NMDA responses and causes long-term protein synthesis-dependent modulation of the lamprey locomotor network. J Neurosci (1998) 0.80
Amphetamine in recovery from brain injury. Brain Inj (1996) 0.79
A substance P antagonist increases brain intracellular free magnesium concentration after diffuse traumatic brain injury in rats. J Am Coll Nutr (2004) 0.79
Learning and memory in S100-beta transgenic mice: an analysis of impaired and preserved function. Neurobiol Learn Mem (2001) 0.79
Acetylcholine and choline dynamics provide early and late markers of traumatic brain injury. Brain Res (2006) 0.78
Changes of mGluR4 and the effects of its specific agonist L-AP4 in a rodent model of diffuse brain injury. J Clin Neurosci (2003) 0.78
Novel therapies in development for the treatment of traumatic brain injury. Expert Opin Investig Drugs (2002) 0.78
Distinct regulations by septide and the neurokinin-1 tachykinin receptor agonist [pro9]substance P of the N-methyl-D-aspartate-evoked release of dopamine in striosome- and matrix-enriched areas of the rat striatum. Neuroscience (1996) 0.78
Abnormal APP processing in platelets of patients with Alzheimer's disease: correlations with membrane fluidity and cognitive decline. Psychopharmacology (Berl) (2007) 0.78
Cholinergic dysfunction and cognitive impairment after traumatic brain injury. Part 2: evidence from basic and clinical investigations. J Head Trauma Rehabil (2011) 0.76
The use of cholinesterase in severe head injury. Resuscitation (1975) 0.76
Involvement of indoleamines in functional disturbances after brain injury. Prog Neuropsychopharmacol Biol Psychiatry (1989) 0.76
Tg2576 cortical neurons that express human Ab are susceptible to extracellular Aβ-induced, K+ efflux dependent neurodegeneration. PLoS One (2011) 0.75
Effect of anti-depressants on neuro-behavioural consequences following impact accelerated traumatic brain injury in rats. Indian J Exp Biol (2010) 0.75
S100B infusion into the rat hippocampus facilitates memory for the inhibitory avoidance task but not for the open-field habituation. Physiol Behav (2001) 0.75
Endogenous neuropeptides in patients with acute traumatic head injury. II: Changes in the levels of cerebrospinal fluid substance P, serotonin and lipid peroxidation products in patients with head trauma. Neuropeptides (1997) 0.75
Upregulation of SATB1 is associated with the development and progression of glioma. J Transl Med (2012) 1.24
Correlation of low SLC22A18 expression with poor prognosis in patients with glioma. J Clin Neurosci (2011) 1.03
Promoter methylation and downregulation of SLC22A18 are associated with the development and progression of human glioma. J Transl Med (2011) 1.03
Quantitative evaluation of microscopic injury with diffusion tensor imaging in a rat model of diffuse axonal injury. Eur J Neurosci (2011) 1.03
c-Met-targeted RNA interference inhibits growth and metastasis of glioma U251 cells in vitro. J Neurooncol (2009) 0.98
Diffuse axonal injury: novel insights into detection and treatment. J Clin Neurosci (2009) 0.95
Effect of 5-Aza-2'-deoxycytidine on SLC22A18 in glioma U251 cells. Mol Med Rep (2011) 0.94
Stabilization of hepatocyte growth factor mRNA by hypoxia-inducible factor 1. Mol Biol Rep (2008) 0.89
Hydroxyapatite nanoparticles inhibit the growth of human glioma cells in vitro and in vivo. Int J Nanomedicine (2012) 0.89
Expression of HGF and VEGF in the cerebral tissue of adult rats with chronic hydrocephalus after subarachnoid hemorrhage. Mol Med Rep (2011) 0.87
Elevated expression of solute carrier family 22 member 18 increases the sensitivity of U251 glioma cells to BCNU. Oncol Lett (2011) 0.87
Biomarkers associated with diffuse traumatic axonal injury: exploring pathogenesis, early diagnosis, and prognosis. J Trauma (2010) 0.86
c-Met antisense oligodeoxynucleotides increase sensitivity of human glioma cells to paclitaxel. Oncol Rep (2010) 0.85
Stem/progenitor cells: a potential source of retina-specific cells for retinal repair. Neurosci Res (2009) 0.84
Exploring temporospatial changes in glucose metabolic disorder, learning, and memory dysfunction in a rat model of diffuse axonal injury. J Neurotrauma (2012) 0.82
From the vascular microenvironment to neurogenesis. Brain Res Bull (2010) 0.82
Overexpression of Wnt3a facilitates the proliferation and neural differentiation of neural stem cells in vitro and after transplantation into an injured rat retina. J Neurosci Res (2013) 0.82
Correlation between SATB1 and Bcl-2 expression in human glioblastoma multiforme. Mol Med Rep (2012) 0.80
Detection of white matter lesions in the acute stage of diffuse axonal injury predicts long-term cognitive impairments: a clinical diffusion tensor imaging study. J Trauma Acute Care Surg (2013) 0.79
In vitro and in vivo radiosensitization induced by hydroxyapatite nanoparticles. Neuro Oncol (2013) 0.79
c-Met antisense oligodeoxynucleotides as a novel therapeutic agent for glioma: in vitro and in vivo studies of uptake, effects, and toxicity. J Surg Res (2007) 0.78
Predictive value of the SLC22A18 protein expression in glioblastoma patients receiving temozolomide therapy. J Transl Med (2013) 0.78
Relationship between SATB1 expression and prognosis in astrocytoma. J Clin Neurosci (2013) 0.77
Insight into astrocyte activation after optic nerve injury. J Neurosci Res (2014) 0.77
Inhibition of human glioma U251 cells growth in vitro and in vivo by hydroxyapatite nanoparticle-assisted delivery of short hairpin RNAs against SATB1. Mol Biol Rep (2013) 0.75
Glial cells activation potentially contributes to the upregulation of stromal cell-derived factor-1α after optic nerve crush in rats. Neurochem Res (2013) 0.75